Hercules Technology Growth Capital, Inc. (HTGC) - 2014 Annual Report Summary
Business Context and Reporting Period
This summary covers the Form 10-K for the fiscal year ended December 31, 2014. Hercules Technology Growth Capital, Inc. (HTGC) is an internally managed, non-diversified closed-end investment company regulated as a Business Development Company (BDC) and a Regulated Investment Company (RIC). The company focuses on providing senior secured loans, primarily structured debt with warrants, to venture capital-backed companies in technology-related industries, including biotechnology, life sciences, software, and energy technology.
Key Financial Metrics
| Metric | 2014 Value | 2013 Value |
|---|---|---|
| Total Assets | $1,299.2 million | $1,221.7 million |
| Total Investments (at value) | $1,020.7 million | $910.3 million |
| Total Liabilities | $640.4 million | $571.7 million |
| Total Net Assets | $658.9 million | $650.0 million |
| Net Asset Value (NAV) per Share | $10.18 | $10.51 |
| Total Investment Income | $143.7 million | $139.7 million |
| Net Investment Income | $71.8 million | $73.1 million |
| Net Realized Gain | $20.1 million | $14.8 million |
| Net Unrealized Depreciation | ($20.7 million) | $11.5 million (Appreciation) |
| Net Increase in Net Assets from Operations | $71.2 million | $99.4 million |
| Dividends Declared per Share | $1.24 | $1.11 |
Material Changes vs. Prior Period
- Portfolio Growth: The total fair value of the investment portfolio increased by approximately 12.1% to $1.02 billion, driven by new fundings of $566.6 million and restructure fundings of $54.7 million.
- Yield Performance: The effective yield on debt investments increased to 16.8% in 2014 from 15.9% in 2013, while the core yield (excluding fee accelerations) decreased slightly to 13.6% from 14.4%.
- Unrealized Depreciation: The company recorded a net unrealized depreciation of $20.7 million in 2014, a significant shift from the $11.5 million appreciation in 2013. This was primarily due to collateral-based impairments on debt investments ($23.2 million) and warrant depreciation related to the exercise of warrants in Box, Inc. and Neuralstem, Inc.
- Debt Structure: The company issued $103.0 million in 2024 Notes and $129.3 million in 2021 Asset-Backed Notes. Conversely, it settled $57.3 million of Convertible Senior Notes and repaid $34.8 million of SBA debentures.
- Operating Expenses: Total operating expenses rose to $70.3 million from $66.6 million, largely due to increased stock-based compensation ($9.6 million vs. $6.0 million) and general administrative costs.
Guidance, Outlook, and Risks
Management Commentary & Outlook: Management maintains a variable dividend policy targeting the distribution of 90-100% of taxable income. The company intends to distribute approximately $16.7 million of spillover earnings from 2014 in 2015. The Board approved a $50.0 million share repurchase program in February 2015. The company continues to focus on originating new investments, with $150.8 million in closed commitments and $36.0 million in pending commitments as of late February 2015.
Risks and Contingencies:
- Valuation Risk: Approximately 78.6% of total assets are Level 3 investments valued by the Board of Directors, creating inherent uncertainty in fair value determinations.
- Liquidity and Leverage: The company is subject to a 200% asset coverage ratio requirement under the 1940 Act. As of year-end, the ratio was 250.8% (excluding SBA debentures). Total leverage including SBA debentures was 205.0%.
- Portfolio Concentration: The portfolio is concentrated in technology-related sectors. The top four industries (Drug Discovery, Medical Devices, Software, Drug Delivery) comprised 60.7% of the portfolio. Three portfolio companies represented over 5% of net assets each.
- Securitization Risks: The company holds equity interests in securitization trusts. A "Rapid Amortization Event" was triggered in February 2015 for the 2017 Asset-Backed Notes, requiring accelerated principal payments.
- Convertible Notes: Remaining Convertible Senior Notes ($17.7 million principal) are convertible through March 31, 2015, potentially causing dilution.
Key Facts for Investor Verification
- Dividend Sustainability: Verify the tax characterization of the $1.24 per share dividend paid in 2014 and the ability to fund the $16.7 million spillover distribution in 2015 given the net unrealized depreciation.
- Asset Coverage Ratio: Monitor the asset coverage ratio closely, particularly as the 2017 Asset-Backed Notes undergo rapid amortization and if further Convertible Notes are converted.
- Portfolio Quality: Review the specific portfolio companies contributing to the $23.2 million in collateral-based impairments and the status of the four debt investments on non-accrual status (cost $28.9 million, fair value $10.6 million).
- Unfunded Commitments: Assess the company's liquidity to fund the $339.0 million in unfunded contractual commitments, noting that $191.3 million is contingent on portfolio company milestones.
- Share Repurchase Program: Track the execution of the newly authorized $50.0 million share repurchase program and its impact on NAV per share.